Editas Medicine Inc (EDIT)
5.208
+0.04
(+0.73%)
USD |
NASDAQ |
May 31, 16:00
5.20
-0.01
(-0.14%)
After-Hours: 20:00
Editas Medicine Shareholders Equity (Quarterly): 294.40M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 294.40M |
December 31, 2023 | 349.10M |
September 30, 2023 | 360.46M |
June 30, 2023 | 399.92M |
March 31, 2023 | 317.47M |
December 31, 2022 | 360.68M |
September 30, 2022 | 414.74M |
June 30, 2022 | 465.41M |
March 31, 2022 | 512.76M |
December 31, 2021 | 553.64M |
September 30, 2021 | 586.79M |
June 30, 2021 | 613.36M |
March 31, 2021 | 638.00M |
December 31, 2020 | 393.59M |
September 30, 2020 | 441.15M |
June 30, 2020 | 426.77M |
March 31, 2020 | 234.57M |
December 31, 2019 | 262.44M |
Date | Value |
---|---|
September 30, 2019 | 209.99M |
June 30, 2019 | 193.06M |
March 31, 2019 | 217.16M |
December 31, 2018 | 236.16M |
September 30, 2018 | 224.45M |
June 30, 2018 | 231.33M |
March 31, 2018 | 247.52M |
December 31, 2017 | 208.08M |
September 30, 2017 | 177.79M |
June 30, 2017 | 185.00M |
March 31, 2017 | 206.46M |
December 31, 2016 | 134.61M |
September 30, 2016 | 170.18M |
June 30, 2016 | 187.33M |
March 31, 2016 | 201.36M |
December 31, 2015 | -83.11M |
September 30, 2015 | 127.62M |
December 31, 2014 | -15.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
193.06M
Minimum
Jun 2019
638.00M
Maximum
Mar 2021
401.42M
Average
396.75M
Median
Shareholders Equity (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 18.55B |
Bristol-Myers Squibb Co | 16.49B |
Regeneron Pharmaceuticals Inc | 26.99B |
Cabaletta Bio Inc | 221.72M |
Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 440.35M |
Total Liabilities (Quarterly) | 145.95M |
Current Ratio | 4.596 |